Hemogenyx Pharmaceuticals Plc (5HU0)
Market Closed
11 Aug, 20:00
XFRA 
€
7. 25
0
0%
€
59.04M Market Cap
- P/E Ratio
- Div Yield
43 Volume
- Eps
€ 7.25
Previous Close Want to track 5HU0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Hemogenyx Pharmaceuticals Plc (5HU0) Statistics
Valuation metrics
Market Cap 59.04M
Enterprise value 52.61M
Trailing P/E (ttm) -4.97
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) -
Enterprise Value/Revenue -
Enterprise Value/EBITDA -9.19
Overview
Shares outstanding 4.59M
Float 3.62M
Shares short -
% Held by insiders 0.31%
% Held by institutions 0.01%
Average volume (10 days) 9
Average volume (90 days) 29
Price summary
52-Week low 1.47
52-Week high 18.9
Beta 1.54
50-Day moving average 11.23
200-Day moving average 8.65
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:400
Last split Date 13 Dec 2024
Financials
Fiscal year
Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.71%
Return on equity -6.31%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -1.3M
EBITDA -5.73M
Net income to common (ttm) -8.97M
Diluted EPS (ttm) -2.65
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 260.42K
Total cash per share (mrq) 0.05
Total debt (mrq) 2.53M
Total Debt/Equity (mrq) -4.63
Current ratio (mrq) 0.43%
Book value per share (mrq) -0.13
Cash Flow
Cash flow statement -6.4M
Levered free cash flow (LFCF) -1.27M
